From the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia (L.C.B., S.T.Y., R.R., C.N.M.); Baker IDI Heart and Diabetes Institute, Central Clinical School Monash University, Melbourne, Victoria, Australia (M.P.S., G.W.L.); and Department of Physiology, Cardiovascular Division, Federal University of São Paulo, São Paulo, Brazil (E.E.N.).
Hypertension. 2015 Feb;65(2):393-400. doi: 10.1161/HYPERTENSIONAHA.114.04176. Epub 2014 Nov 17.
Previous studies indicate that catheter-based renal denervation reduces blood pressure and renal norepinephrine spillover in human resistant hypertension. The effects of this procedure on afferent sensory and efferent sympathetic renal nerves, and the subsequent degree of reinnervation, have not been investigated. We therefore examined the level of functional and anatomic reinnervation at 5.5 and 11 months after renal denervation using the Symplicity Flex catheter. In normotensive anesthetized sheep (n=6), electric stimulation of intact renal nerves increased arterial pressure from 99±3 to 107±3 mm Hg (afferent response) and reduced renal blood flow from 198±16 to 85±20 mL/min (efferent response). In a further group (n=6), immediately after denervation, renal sympathetic nerve activity was absent and the responses to electric stimulation were abolished. At 11 months after denervation (n=5), renal sympathetic nerve activity and the responses to electric stimulation were at normal levels. Immunohistochemical staining for renal efferent (tyrosine hydroxylase) and renal afferent nerves (calcitonin gene-related peptide), as well as renal norepinephrine levels, was normal 11 months after denervation. Findings at 5.5 months after denervation were similar (n=5). In summary, catheter-based renal denervation effectively ablated the renal afferent and efferent nerves in normotensive sheep. By 11 months after denervation the functional afferent and efferent responses to electric stimulation were normal. Reinnervation at 11 months after denervation was supported by normal anatomic distribution of afferent and efferent renal nerves. In view of this evidence, the mechanisms underlying the prolonged hypotensive effect of catheter-based renal denervation in human resistant hypertension need to be reassessed.
先前的研究表明,基于导管的肾脏去神经支配可降低人类难治性高血压患者的血压和肾去甲肾上腺素溢出。但是,尚未研究该程序对传入感觉和传出交感神经肾神经的影响以及随后的再神经支配程度。因此,我们使用 Symplicity Flex 导管在去神经支配后 5.5 和 11 个月检查了功能和解剖再神经支配的程度。在正常血压麻醉绵羊中(n=6),完整肾神经的电刺激使动脉压从 99±3mmHg 增加到 107±3mmHg(传入反应),并使肾血流量从 198±16mL/min 减少到 85±20mL/min(传出反应)。在另一组(n=6)中,去神经支配后立即,肾交感神经活性消失,电刺激的反应被消除。去神经支配后 11 个月(n=5),肾交感神经活性和电刺激的反应恢复正常。去神经支配后 11 个月,肾传出(酪氨酸羟化酶)和肾传入神经(降钙素基因相关肽)的免疫组织化学染色以及肾去甲肾上腺素水平正常。去神经支配后 5.5 个月的发现相似(n=5)。总而言之,基于导管的肾脏去神经支配可有效地消融正常血压绵羊的肾传入和传出神经。去神经支配后 11 个月,电刺激的功能传入和传出反应正常。11 个月后的再神经支配得到传入和传出肾神经的正常解剖分布的支持。鉴于这些证据,需要重新评估基于导管的肾脏去神经支配在人类难治性高血压中引起的降压作用的长期机制。